Thymectomy in Pemphigus Foliaceus: A Thirty-Year Observation

Area of Science:

• Immunology
• Neurology
• Dermatology

Background:

• Myasthenia gravis is a common autoimmune disease treated with thymectomy.
• Pemphigus foliaceus is an autoimmune condition managed medically, with thymectomy reserved for thymoma cases.
• The role of thymectomy in autoimmune disorders without thymoma is less understood.

Observation:

• A young patient presented with both generalized myasthenia gravis and pemphigus foliaceus without thymoma.
• This unique case presented a natural experiment to evaluate thymectomy's impact on autoimmune antibody response.
• The patient underwent total thymectomy surgery.

Findings:

• Postoperative assessment revealed altered immunologic antibody responsiveness.
• The patient experienced over 25 years of clinical remission for both myasthenia gravis and pemphigus foliaceus.
• Total thymectomy was associated with sustained remission in these concurrent autoimmune conditions.

Implications:

• Thymectomy may be a viable therapeutic option for select autoimmune diseases beyond myasthenia gravis.
• Understanding thymectomy's immunomodulatory effects can refine treatment strategies for autoimmune disorders.
• This case highlights the potential of surgical intervention in managing complex autoimmune presentations.